FDA Panel Endorses Genzyme’s Synvisc-One Knee Therapy
By
Jessica Bylander / Email the Author / “The Gray Sheet” Dec. 15, 2008, Vol. 34, No. 050
Advisory Panels / Word Count: 621 / Article # 01340500007
Executive Summary
FDA's Orthopedic and Rehabilitation Devices advisory panel voted unanimously last week to recommend approval of Genzyme's PMA supplement for a single-dose version of its hyaluronic acid-based osteoarthritis knee therapy
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.